Table 6.
Risk of Infection With Closely Related Human Papillomavirus (HPV) Types During Follow-up Among Women Seropositive Versus Those Seronegative for HPV16 or HPV18 and DNA Negative for the Related Genotype at Baseline
| Variable | DNA-Positive Test Result at Any Follow-up Visit |
DNA-Positive Test Result at Any 2 Follow-up Visits |
DNA-Positive Test Result at Any 2 Sequential Follow-up Visits |
|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| HPV16 seropositive (vs seronegative) | |||
| HPV31 | 0.66 (.38–1.15) | 0.59 (.22–1.54) | 0.62 (.23–1.61) |
| HPV33 | 0.72 (.20–2.53) | 0.72 (.20–2.53) | 0.52 (.11–2.32) |
| HPV52 | 1.12 (.78–1.62) | 0.95 (.54–1.68) | 1.03 (.57–1.85) |
| HPV58 | 1.20 (.72–1.96) | 0.70 (.26–1.84) | 0.77 (.29–2.04) |
| HPV18 seropositive (vs seronegative) | |||
| HPV45 | 1.19 (.74–1.92) | 0.99 (.40–2.45) | 1.06 (.39–2.87) |
Abbreviations: CI, confidence interval; OR, odds ratio.